McMillan NAJ - Search Results

1

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants.

Isaacs A, Amarilla AA, Aguado J, Modhiran N, Albornoz EA, Baradar AA, McMillan CLD, Choo JJY, Idris A, Supramaniam A, McMillan NAJ, Muller DA, Young PR, Woodruff TM, Wolvetang EJ, Chappell KJ, Watterson D. Isaacs A, et al. Among authors: mcmillan cld, mcmillan naj. Front Immunol. 2022 Jun 10;13:926262. doi: 10.3389/fimmu.2022.926262. eCollection 2022. Front Immunol. 2022. PMID: 35757714 Free PMC article.

2

Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.

Shaikh MH, Idris A, Johnson NW, Fallaha S, Clarke DTW, Martin D, Morgan IM, Gabrielli B, McMillan NAJ. Shaikh MH, et al. Among authors: mcmillan naj. Oral Oncol. 2018 Nov;86:105-112. doi: 10.1016/j.oraloncology.2018.09.006. Epub 2018 Sep 19. Oral Oncol. 2018. PMID: 30409290

3

Development of novel lipidic particles for siRNA delivery that are highly effective after 12 months storage.

Clarke D, Idris A, McMillan NAJ. Clarke D, et al. Among authors: mcmillan naj. PLoS One. 2019 Feb 8;14(2):e0211954. doi: 10.1371/journal.pone.0211954. eCollection 2019. PLoS One. 2019. PMID: 30735545 Free PMC article.

4

cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.

Shaikh MH, Bortnik V, McMillan NA, Idris A. Shaikh MH, et al. Microb Pathog. 2019 Jul;132:162-165. doi: 10.1016/j.micpath.2019.05.004. Epub 2019 May 2. Microb Pathog. 2019. PMID: 31054871

5

Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237.

Tayyar Y, Shiels R, Bulmer AC, Lam AK, Clarke D, Idris A, McMillan NA. Tayyar Y, et al. PLoS One. 2019 Nov 27;14(11):e0225774. doi: 10.1371/journal.pone.0225774. eCollection 2019. PLoS One. 2019. PMID: 31774882 Free PMC article.

6

Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells.

Bortnik V, Wu M, Julcher B, Salinas A, Nikolic I, Simpson KJ, McMillan NA, Idris A. Bortnik V, et al. J Microbiol Immunol Infect. 2021 Aug;54(4):733-739. doi: 10.1016/j.jmii.2020.07.010. Epub 2020 Jul 30. J Microbiol Immunol Infect. 2021. PMID: 32768338 Free article.

7

Smart drug combinations for cervical cancer: dual targeting of Bcl-2 family of proteins and aurora kinases.

Yumol J, Gabrielli B, Tayyar Y, McMillan NA, Idris A. Yumol J, et al. Am J Cancer Res. 2020 Oct 1;10(10):3406-3414. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163279 Free PMC article.

8

A "hit-and-run" affair - A possible link for cancer progression in virally driven cancers.

Ferreira DA, Tayyar Y, Idris A, McMillan NAJ. Ferreira DA, et al. Among authors: mcmillan naj. Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188476. doi: 10.1016/j.bbcan.2020.188476. Epub 2020 Nov 10. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33186643 Review.

9

Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.

Liu X, Zaid A, Freitas JR, McMillan NA, Mahalingam S, Taylor A. Liu X, et al. mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21. mBio. 2021. PMID: 33879586 Free PMC article.

10

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

Idris A, Davis A, Supramaniam A, Acharya D, Kelly G, Tayyar Y, West N, Zhang P, McMillan CLD, Soemardy C, Ray R, O'Meally D, Scott TA, McMillan NAJ, Morris KV. Idris A, et al. Among authors: mcmillan cld, mcmillan naj. bioRxiv [Preprint]. 2021 Apr 19:2021.04.19.440531. doi: 10.1101/2021.04.19.440531. bioRxiv. 2021. PMID: 33907744 Free PMC article. Updated. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page